Chemotherapy Definitions and Policies for Thymic Malignancies

Chemotherapy Definitions and Policies for Thymic Malignancies

Bibliographic Details
Main Authors:	Nicolas Girard, Rohit Lal, Heather Wakelee, Gregory J. Riely, Patrick J. Loehrer
Format:	Article
Language:	zho
Published:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-02-01
Series:	Chinese Journal of Lung Cancer
Subjects:	Lung neoplasms
Online Access:	http://dx.doi.org/10.3779/j.issn.1009-3419.2014.02.09

Similar Items

Standard Outcome Measures for Thymic Malignancies
by: James Huang, et al.
Published: (2014-02-01)

Radiation Therapy Definitions and Reporting Guidelines for Thymic Malignancies
by: Daniel Gomez, et al.
Published: (2014-02-01)

The Masaoka-Koga Stage Classification for Thymic Malignancies  Clarification and Definition of Terms
by: Frank C. Detterbeck, et al.
Published: (2014-02-01)

Advances on Diagnosis and Treatment of Malignant Thymic Tumors
by: Jinghui WANG, et al.
Published: (2010-10-01)

Which Way is Up? Policies and Procedures for Surgeons and Pathologists Regarding Resection Specimens of Thymic Malignancy
by: Frank C. Detterbeck, et al.
Published: (2014-02-01)

Thymic Tumors Preface
by: Keneng CHEN, et al.
Published: (2014-02-01)

Thematic Introduction of Thymic Tumors
by: Wentao FANG, et al.
Published: (2016-07-01)

Standard Terms, Definitions, and Policies for Minimally Invasive Resection of Thymoma
by: Alper Toker, et al.
Published: (2014-02-01)

Erratum: Pretreatment Biopsy for Histological Diagnosis and Induction Therapy in Thymic Tumors
by: Editorial Office of Chinese Journal of Lung Cancer
Published: (2016-09-01)

Management of Thymic Tumors - Consensus Based on the Chinese Alliance for Research in Thymomas Multi-institutional Retrospective Studies
by: Wentao FANG, et al.
Published: (2016-07-01)

Diagnosis and Treatment of Malignant Pleural Mesothelioma
by: Zhilong ZHAO, et al.
Published: (2009-01-01)

Protein Kinase CK2 and Human Malignant Tumors
by: Yixuan HUANG, et al.
Published: (2012-07-01)

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
by: Giuseppe GIACCONE, et al.
Published: (2010-03-01)

Chemotherapy of Advanced Non-small Cell Lung Cancer in Elderly Patients
by: Xin NIE, et al.
Published: (2009-03-01)

Advances of maintenance chemotherapy on advanced non-small cell lung cancer
by: Xinghao AI, et al.
Published: (2008-02-01)

The study progress of second-line chemotherapy of small cell lung cancer
by: Qian MIAO, et al.
Published: (2008-08-01)

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
by: A. Scherpereel, et al.
Published: (2010-10-01)

The Changes of the first-line Chemotherapy on Advanced non-small Cell Lung Cancer
by: Baohui HAN, et al.
Published: (2008-04-01)

Chemotherapy on nonresectable stage Ⅲ N2 non-small cell lung cancer
by: Li ZHANG
Published: (2008-10-01)

Perioperative chemotherapy of stage Ⅲ N2 non-small cell lung cancer
by: Shun LU, et al.
Published: (2008-10-01)

The pharmacoeconomic efficacy of chemotherapy for malignant neoplasms of the bronchus and lung
by: S. K. Yarovoy, et al.
Published: (2020-04-01)

A Functional Domain Analysis of the BAG Family Proteins and the Relationship with Human Malignancy
by: Ying LI, et al.
Published: (2009-08-01)

Evaluation of Efficacy of Gefitinib on Advanced non-small-cell Lung Cancer (NSCLC) Resisted to Chemotherapy
by: Jiangjiang TU, et al.
Published: (2008-04-01)

Application of Flexi-rigid Thoracoscopy Under Local Anesthesia to Diagnose Malignant Pleural Effusion
by: Chenghui WANG, et al.
Published: (2009-05-01)

Selection of Therapy Method for Stage Ⅲ Non Small Cell Lung Cancer after Induction Chemotherapy
by: Zhendong HU, et al.
Published: (2009-08-01)

Adjuvant chemotherapy options for early stage non-small cell lung cancer
by: Manali ePatel, et al.
Published: (2011-11-01)

Percutaneous ablation of malignant thoracic tumors
by: B Ghaye
Published: (2013-05-01)

Thymic Carcinomas and Second Malignancies: A Single-Center Review
by: Sunil S. Badve, et al.
Published: (2021-05-01)

Policies and Reporting Guidelines for Small Biopsy Specimens of Mediastinal Masses
by: Alberto Marchevsky, et al.
Published: (2014-02-01)

ERCC1 and Class Ⅲ β-tubulin Protein Expression in Relation to Tumour Response and Survival of Stage ⅢB/Ⅳ NSCLC Patients Treated with TP/NP Chemotherapy Regimens
by: Yongying XIAO, et al.
Published: (2009-01-01)

The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy
by: Yanzhi CHEN, et al.
Published: (2008-06-01)

Huge thymic cyst in an adult
by: N Karabulut, et al.
Published: (2012-05-01)

Chemotherapy of lung cancer in the elderly
by: Radosavljević Davorin Z.
Published: (2002-01-01)

Malignant Transformation of Pulmonary Benign Metastasizing Leiomyoma
by: Kyung Sub Song, et al.
Published: (2017-02-01)

Thymic carcinoma
by: Vitória Homem Machado, et al.
Published: (2016-10-01)

Thymic carcinoma
by: Vitória Homem Machado, et al.
Published: (2016-10-01)

Safety Analysis of Ambulatory Chemotherapy in Lung Cancer
by: Yun FENG, et al.
Published: (2010-07-01)

Acceptable Safety of Bevacizumab Therapy in Combination with Chemotherapy in Patients with Advanced Lung Cancer
by: Wei WU, et al.
Published: (2009-03-01)

Mobocertinib (TAK-788) in <em>EGFR</em> Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort
by: Maria Rosario Garcia Campelo, et al.
Published: (2022-12-01)

Editorial: Novel Treatments for Thymoma and Thymic Carcinoma
by: Arun eRajan, et al.
Published: (2015-11-01)